A
47
-4
UHS
64
-2
CLX
44
-2
SRE
57
-2
ZBH
50
3
PSX
47
2
SE
80
-8
M
36
-3
KMI
71
2
CME
70
3
ECL
45
-2
PEP
27
-2
ETN
71
2
STI
24
-27
O
35
2
CVS
58
-2
ADI
63
2
MAT
52
-3
WDC
61
-2
K
54
-5
A
47
-4
UHS
64
-2
CLX
44
-2
SRE
57
-2
ZBH
50
3
PSX
47
2
SE
80
-8
M
36
-3
KMI
71
2
CME
70
3
ECL
45
-2
PEP
27
-2
ETN
71
2
STI
24
-27
O
35
2
CVS
58
-2
ADI
63
2
MAT
52
-3
WDC
61
-2
K
54
-5
Financhill
Back

Soleno Therapeutics Stock Predictions

Former Zillow execs target $1.3T market

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
75

SLNO
Soleno Therapeutics

Last Price:
$76.73
Seasonality Move:
-7.25%

7 Day Trial

ALL ACCESS PASS

$ 7

Top investors are buying this "unlisted" stock

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Soleno Therapeutics Stock Forecast

  • Over the next 52 weeks, Soleno Therapeutics has on average historically risen by 97.9% based on the past 10 years of stock performance.
  • Soleno Therapeutics has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Soleno Therapeutics Stock Undervalued?
    The current Soleno Therapeutics [SLNO] share price is $76.78. The Score for SLNO is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • SLNO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Soleno Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Soleno Therapeutics has on average historically risen by 97.9% based on the past 10 years of stock performance.

Soleno Therapeutics Stock Rating

Buy
75
Soleno Therapeutics (SLNO) is a Buy

Is Soleno Therapeutics overpriced?

  • Soleno Therapeutics has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Soleno Therapeutics Stock Price History

Is SLNO stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SLNO is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
soleno.life

52-Week Data

52-Week High:
80.99
52-Week Low:
36.93

Prediction Charts

Market Cap:
3.9B
Price in USD:
76.78
Volume:
950.9K
Beta:
-0.34

Technical Analysis

SMA50:
62.18
SMA100:
54.67
SMA200:
52.87
52-Wk Change:
61.17%

Stock Predictions

  • Is Soleno Therapeutics stock public?
    Yes, Soleno Therapeutics is a publicly traded company.
  • What is the Soleno Therapeutics stock quote today?
    The Soleno Therapeutics stock price is 76.78 USD today.
  • How to buy Soleno Therapeutics stock online?
    You can buy Soleno Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-22 69.10 71.40 71.99 69.10
Apr-23 72.85 72.27 74.50 71.73
Apr-24 73.24 74.23 74.28 71.20
Apr-25 74.24 73.26 74.27 72.78
Apr-28 72.75 73.64 74.25 71.24
Apr-29 73.44 75.27 76.56 72.75
Apr-30 74.23 74.86 75.70 73.08
May-1 74.70 75.02 75.96 72.50
May-2 75.95 75.23 76.16 74.74
May-5 74.99 76.49 76.60 74.03
May-6 75.85 73.71 76.05 72.23
May-7 73.77 74.66 75.79 73.20
May-8 75.66 76.26 80.99 74.66
May-9 75.97 76.78 78.56 75.50

Soleno Therapeutics Earnings

Soleno Therapeutics Earnings Report: Per Share Soleno Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Soleno Therapeutics Forecast Revenue Growth

Soleno Therapeutics Stock Analysis: Historical quarterly revenues per share for Soleno Therapeutics and historical quarterly revenue growth:

* Soleno Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.